FI935073A - Nya tiopyranopyrrolderivat, framstaellning av dem och dessa innehaollande farmaceutiska sammansaettningar - Google Patents
Nya tiopyranopyrrolderivat, framstaellning av dem och dessa innehaollande farmaceutiska sammansaettningar Download PDFInfo
- Publication number
- FI935073A FI935073A FI935073A FI935073A FI935073A FI 935073 A FI935073 A FI 935073A FI 935073 A FI935073 A FI 935073A FI 935073 A FI935073 A FI 935073A FI 935073 A FI935073 A FI 935073A
- Authority
- FI
- Finland
- Prior art keywords
- tiopyranopyrrolderivat
- nya
- framstaellning
- sammansaettningar
- dessa innehaollande
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9106037A FR2676446B1 (fr) | 1991-05-17 | 1991-05-17 | Nouveaux derives du thiopyranopyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent. |
PCT/FR1992/000431 WO1992020685A1 (fr) | 1991-05-17 | 1992-05-15 | Nouveaux derives du thiopyranopyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent |
Publications (2)
Publication Number | Publication Date |
---|---|
FI935073A0 FI935073A0 (fi) | 1993-11-16 |
FI935073A true FI935073A (fi) | 1993-11-16 |
Family
ID=9412909
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI935073A FI935073A (fi) | 1991-05-17 | 1993-11-16 | Nya tiopyranopyrrolderivat, framstaellning av dem och dessa innehaollande farmaceutiska sammansaettningar |
Country Status (17)
Country | Link |
---|---|
EP (2) | EP0514275A1 (fi) |
JP (1) | JPH06507894A (fi) |
AU (1) | AU653033B2 (fi) |
CA (1) | CA2109296A1 (fi) |
CZ (1) | CZ244993A3 (fi) |
FI (1) | FI935073A (fi) |
FR (1) | FR2676446B1 (fi) |
HU (1) | HUT70490A (fi) |
IE (1) | IE921543A1 (fi) |
IL (1) | IL101864A0 (fi) |
MX (1) | MX9202289A (fi) |
NO (1) | NO934146L (fi) |
NZ (1) | NZ242737A (fi) |
SK (1) | SK126993A3 (fi) |
TW (1) | TW201748B (fi) |
WO (1) | WO1992020685A1 (fi) |
ZA (1) | ZA923513B (fi) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2676447B1 (fr) * | 1991-05-17 | 1993-08-06 | Rhone Poulenc Rorer Sa | Nouveaux derives du thiopyranopyrrole et leur preparation. |
FR2725900B1 (fr) * | 1994-10-21 | 1997-07-18 | Sanofi Sa | Utilisation d'antagonistes des recepteurs nk1 pour la preparation de medicaments a action cardioregulatrice |
FR2728166A1 (fr) | 1994-12-19 | 1996-06-21 | Oreal | Composition topique contenant un antagoniste de substance p |
FR2728169A1 (fr) | 1994-12-19 | 1996-06-21 | Oreal | Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales |
FR2728165A1 (fr) | 1994-12-19 | 1996-06-21 | Oreal | Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene |
FR2733750B1 (fr) * | 1995-05-03 | 1997-06-13 | Synthelabo | Derives de l'acide gamma-oxo-alpha-(phenylmethyl)-5,6- dihydro-4h-thieno(3,4-c)pyrrole-5-butanoique, leur preparation et leur application en therapeutique |
FR2741262B1 (fr) | 1995-11-20 | 1999-03-05 | Oreal | Utilisation d'un antagoniste de tnf-alpha pour le traitement des rougeurs cutanees d'origine neurogene |
FR2777566B1 (fr) | 1998-04-15 | 2003-02-21 | Synthelabo | Derives d'azacycloalcanes, leur preparation et leur application en therapeutique |
US7163949B1 (en) | 1999-11-03 | 2007-01-16 | Amr Technology, Inc. | 4-phenyl substituted tetrahydroisoquinolines and use thereof |
MXPA02004330A (es) | 1999-11-03 | 2004-07-30 | Albany Molecular Res Inc | Tetrahidroisoquinolinas aril-y heteroaril-sustituidas y uso de las mismas para bloquear la recaptacion de norepinefrina, dopamina y serotonina.. |
NZ523456A (en) | 2000-07-11 | 2004-11-26 | Albany Molecular Res Inc | Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
US7541357B2 (en) | 2004-07-15 | 2009-06-02 | Amr Technology, Inc. | Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
ATE550019T1 (de) | 2005-05-17 | 2012-04-15 | Merck Sharp & Dohme | Cis-4-ä(4-chlorophenyl)sulfonylü-4-(2,5- difluorophenyl)cyclohexanepropansäure zur behandlug von krebs |
GEP20125566B (en) | 2005-07-15 | 2012-07-10 | Amr Technology Inc | Aryl-and heteroaryl-substituded tetrahydro-benzazepines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
JP4611444B2 (ja) | 2007-01-10 | 2011-01-12 | イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー | ポリ(adp−リボース)ポリメラーゼ(parp)阻害剤としてのアミド置換インダゾール |
WO2008090114A1 (en) | 2007-01-24 | 2008-07-31 | Glaxo Group Limited | Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-) |
EP3103791B1 (en) | 2007-06-27 | 2018-01-31 | Merck Sharp & Dohme Corp. | 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
AR071997A1 (es) | 2008-06-04 | 2010-07-28 | Bristol Myers Squibb Co | Forma cristalina de 6-((4s)-2-metil-4-(2-naftil)-1,2,3,4-tetrahidroisoquinolin-7-il)piridazin-3-amina |
UA105182C2 (ru) | 2008-07-03 | 2014-04-25 | Ньюрексон, Інк. | Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность |
WO2010114780A1 (en) | 2009-04-01 | 2010-10-07 | Merck Sharp & Dohme Corp. | Inhibitors of akt activity |
PE20120373A1 (es) | 2009-05-12 | 2012-05-17 | Albany Molecular Res Inc | 7-([1,2,4]triazolo[1,5-a]piridin-6-il)-4-(3,4-diclorofenil)-1,2,3,4-tetrahidroisoquinolina |
WO2010132487A1 (en) | 2009-05-12 | 2010-11-18 | Bristol-Myers Squibb Company | CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROHPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF |
CN102458123A (zh) | 2009-05-12 | 2012-05-16 | 阿尔巴尼分子研究公司 | 芳基、杂芳基和杂环取代的四氢异喹啉及其用途 |
JP5099731B1 (ja) | 2009-10-14 | 2012-12-19 | メルク・シャープ・アンド・ドーム・コーポレーション | p53活性を増大する置換ピペリジン及びその使用 |
US8518907B2 (en) | 2010-08-02 | 2013-08-27 | Merck Sharp & Dohme Corp. | RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) |
DK2606134T3 (da) | 2010-08-17 | 2019-07-22 | Sirna Therapeutics Inc | RNA-Interferens-formidlet inhibering af hepatitis-B-virus (HBV)-genekspression ved hjælp af kort interfererende nukleinsyre (siNA) |
EP2608669B1 (en) | 2010-08-23 | 2016-06-22 | Merck Sharp & Dohme Corp. | NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS |
WO2012030685A2 (en) | 2010-09-01 | 2012-03-08 | Schering Corporation | Indazole derivatives useful as erk inhibitors |
US9242981B2 (en) | 2010-09-16 | 2016-01-26 | Merck Sharp & Dohme Corp. | Fused pyrazole derivatives as novel ERK inhibitors |
DK2632472T3 (en) | 2010-10-29 | 2018-03-19 | Sirna Therapeutics Inc | RNA INTERFERENCE-MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERRING NUCLEIC ACIDS (SINA) |
EP2654748B1 (en) | 2010-12-21 | 2016-07-27 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as erk inhibitors |
US20140045847A1 (en) | 2011-04-21 | 2014-02-13 | Piramal Enterprises Limited | Crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation |
WO2013063214A1 (en) | 2011-10-27 | 2013-05-02 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
EP3358013B1 (en) | 2012-05-02 | 2020-06-24 | Sirna Therapeutics, Inc. | Short interfering nucleic acid (sina) compositions |
RU2660429C2 (ru) | 2012-09-28 | 2018-07-06 | Мерк Шарп И Доум Корп. | Новые соединения, которые являются ингибиторами erk |
AU2013352568B2 (en) | 2012-11-28 | 2019-09-19 | Merck Sharp & Dohme Llc | Compositions and methods for treating cancer |
ES2707305T3 (es) | 2012-12-20 | 2019-04-03 | Merck Sharp & Dohme | Imidazopiridinas sustituidas como inhibidores de HDM2 |
WO2014120748A1 (en) | 2013-01-30 | 2014-08-07 | Merck Sharp & Dohme Corp. | 2,6,7,8 substituted purines as hdm2 inhibitors |
CN103317438B (zh) * | 2013-06-18 | 2015-08-19 | 浙江工业大学 | 动压浮离抛光盘动压浮离位置精密调整机构 |
WO2015034925A1 (en) | 2013-09-03 | 2015-03-12 | Moderna Therapeutics, Inc. | Circular polynucleotides |
EP3706742B1 (en) | 2017-11-08 | 2023-03-15 | Merck Sharp & Dohme LLC | Prmt5 inhibitors |
WO2020033282A1 (en) | 2018-08-07 | 2020-02-13 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
EP3833667B1 (en) | 2018-08-07 | 2024-03-13 | Merck Sharp & Dohme LLC | Prmt5 inhibitors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4042707A (en) * | 1976-02-19 | 1977-08-16 | E. I. Du Pont De Nemours And Company | 3α-Arylhydroisoindoles |
EP0058567B1 (en) * | 1981-02-17 | 1984-07-25 | Warner-Lambert Company | Substituted acyl derivatives of octahydro-1h-isoindole-1-carboxylic acids and esters |
US4439229A (en) * | 1981-06-29 | 1984-03-27 | Rohm And Haas Company | Substituted phthalimides herbicides |
FR2676447B1 (fr) * | 1991-05-17 | 1993-08-06 | Rhone Poulenc Rorer Sa | Nouveaux derives du thiopyranopyrrole et leur preparation. |
-
1991
- 1991-05-17 FR FR9106037A patent/FR2676446B1/fr not_active Expired - Lifetime
-
1992
- 1992-05-14 NZ NZ242737A patent/NZ242737A/en unknown
- 1992-05-14 IL IL101864A patent/IL101864A0/xx unknown
- 1992-05-14 TW TW081103722A patent/TW201748B/zh active
- 1992-05-14 ZA ZA923513A patent/ZA923513B/xx unknown
- 1992-05-15 HU HU9303252A patent/HUT70490A/hu unknown
- 1992-05-15 MX MX9202289A patent/MX9202289A/es unknown
- 1992-05-15 CZ CS932449A patent/CZ244993A3/cs unknown
- 1992-05-15 WO PCT/FR1992/000431 patent/WO1992020685A1/fr not_active Application Discontinuation
- 1992-05-15 CA CA002109296A patent/CA2109296A1/fr not_active Abandoned
- 1992-05-15 SK SK1269-93A patent/SK126993A3/sk unknown
- 1992-05-15 EP EP92401331A patent/EP0514275A1/fr active Pending
- 1992-05-15 EP EP92911395A patent/EP0586486A1/fr not_active Withdrawn
- 1992-05-15 AU AU19140/92A patent/AU653033B2/en not_active Ceased
- 1992-05-15 JP JP4511262A patent/JPH06507894A/ja active Pending
- 1992-07-01 IE IE154392A patent/IE921543A1/en not_active Application Discontinuation
-
1993
- 1993-11-16 NO NO934146A patent/NO934146L/no unknown
- 1993-11-16 FI FI935073A patent/FI935073A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO934146D0 (no) | 1993-11-16 |
HU9303252D0 (en) | 1994-03-28 |
IE921543A1 (en) | 1992-11-18 |
FR2676446B1 (fr) | 1993-08-06 |
NZ242737A (en) | 1993-06-25 |
HUT70490A (en) | 1995-10-30 |
AU653033B2 (en) | 1994-09-15 |
SK126993A3 (en) | 1994-11-09 |
FI935073A0 (fi) | 1993-11-16 |
EP0514275A1 (fr) | 1992-11-19 |
IL101864A0 (en) | 1992-12-30 |
JPH06507894A (ja) | 1994-09-08 |
CA2109296A1 (fr) | 1992-11-18 |
CZ244993A3 (en) | 1994-03-16 |
WO1992020685A1 (fr) | 1992-11-26 |
FR2676446A1 (fr) | 1992-11-20 |
AU1914092A (en) | 1992-12-30 |
ZA923513B (en) | 1993-02-24 |
MX9202289A (es) | 1993-02-01 |
NO934146L (no) | 1993-11-16 |
EP0586486A1 (fr) | 1994-03-16 |
TW201748B (fi) | 1993-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI935073A (fi) | Nya tiopyranopyrrolderivat, framstaellning av dem och dessa innehaollande farmaceutiska sammansaettningar | |
FI935074A (fi) | Nya tiopyranopyrrolderivat och framstaellning av dem | |
FI913917A0 (fi) | 3-amidopyrazolderivat, foerfarande foer framstaellning av dessa och farmaceutiska kompositioner innehaollande dessa. | |
FI922735A0 (fi) | Nya behaollarsystem och vattenhaltiga kompositioner. | |
FI925174A0 (fi) | Nya organokiselfoereningar och kompositioner innehaollande dem | |
FI905510A0 (fi) | Nya bensoxazinderivat och dessa innehaollande farmaceutiska blandningar. | |
FI915697A (fi) | N,o-sulfaterade heparosaner, foerfarande foer deras framstaellning och farmaceutiska kompositioner innehaollande dem. | |
FI925946A (fi) | Nya 2-sackarinylmetylaryl- och -aryloxiacetat anvaendbara som inhibitorer foer proteolytiska ensymer, kompositioner innehaollande dessa och anvaendning av dessa | |
FI910201A0 (fi) | System foer anvaendning av aerosoler och aerosolfoerpackningar. | |
FI933544A0 (fi) | Tiadiazinkarboxamidderivat, foerfaranden foer framstaellning av dem och laekemedel | |
FI922867A0 (fi) | Dikarbonsyraderivat och foerfarande foer framstaellning av dem. | |
FI913888A0 (fi) | Nya farmaceutiska sammansaettningar och foerfarande foer framstaellning av desamma. | |
FI921814A (fi) | 2-aminopyrimidin-4-karboxiamidderivat, deras framstaellning och terapeutisk anvaendning av dem | |
FI901199A0 (fi) | Nya steroiddioler, dessa innehaollande farmaceutiska foereningar och foerfarande foer framstaellning av dem. | |
FI930293A (fi) | Nya heteroaryloxi-b-karboliner, deras framstaellning och anvaendning i laekemedel | |
FI922437A0 (fi) | Tetracykliska antibiotika och foerfarande foer framstaellning av dessa. | |
FI924139A0 (fi) | Skumhindrande/skumreducerande komposition och foerfarande foer anvaendning av denna i vattenhaltiga system. | |
FI915930A0 (fi) | Nya 15-nitro-2b,3b-dihydro- och 15-nitro-2b,3b,6,7-tetrahydrotabersoninderivater, farmaceutiska sammansaettningar innehaollande dem och deras framstaellningsmetod. | |
FI925974A0 (fi) | Humant rotavirus-hcr3, nyorganiserade stammar av detta och vaccinkompositioner innehaollande dessa | |
FI901528A0 (fi) | Nya bronkosplasmolytiska foereningar och ett foerfarande foer framstaellning av dem. | |
FI923304A (fi) | Nya bearbetbara tiofenbaserade polymerer och kopolymerer, och vaermestabila elledande kompositioner daerav | |
FI920997A0 (fi) | Nya amidingrupphaltiga difosforsyrederivat, foerfarande foer framstaellning av dem och laekemedel innehaollande dessa foereningar. | |
FI935170A (fi) | Nya kiralsulfater, framstaellning av dem och anvaendning i syntesen av farmaceutiska foereningar | |
FI924281A0 (fi) | Tienocyklopentanonoximers etrar, deras framstaellning och farmaceutiska sammansaettningar innehaollande dem. | |
FI923156A0 (fi) | Nya kefalosporinfoereningar och foerfaranden foer framstaellning av dem. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |